Bibliometric Analysis of the 103 Most-Cited Articles about COVID-19 in the Intensive Care Field

Abstract

Introduction.:The COVID-19 pandemic affects the whole world and many studies were published about intensive care. Our aim is to assess the characteristics of 103 publications with most citations among literature related to COVID-19 in the intensive care field. Methods: This descriptive cross-sectional study used suitable key words like “COVID-19”, “COVID-2019”, “SARS-CoV-2” and “pandemic” in the “Institute for Scientific Information Web of Science” database to determine the top 103 publications with most citations. Comparison of groups used the Kruskal Wallis and Mann Whitney U tests. Results: Analysis of intensive care literature about COVID-19 up to October 2020 determined 1413 publications. The most-cited study had 1004 citations, while 7 was the minimum citations within the top 103 studies. The mean total citation number for these publications was 49.58±117.63. The most-cited study was by Xu, Zhe et al. in the April 2020 issue of Lancet Respiratory Medicine entitled “Pathological findings of COVID-19 associated with acute respiratory distress syndrome”. When the areas of focus of the top studies are investigated, they were COVID-19 treatment (26.21%), experience and recommendations about COVID-19 (23.30%) and COVID-19 physiopathology (13.59%). Conclusions: Our study is the first to analyze the top 103 studies with most citations related to COVID-19 in the intensive care literature. With the spread of the pandemic, academic articles continue to be published with great speed. Bibliographic studies provide critical information to assess the citation profile and determine the areas of focus. Future intensive care publications about COVID-19 will focus on diagnosis, treatment and physiopathology.

Keywords

• Covid 19
• Intensive Care
• Citations
• Top 103

References

1. 1. Wang C, Horby PW, Hayden FG, et al. A novel coronavirus outbreak of global health concern. Lancet 2020;395:470-3.
2. 2. Montenegro F, Unigarro L, Paredes G et al. Acute respiratory distress syndrome (ARDS) caused by the novel coronavirus disease (COVID-19): A practical comprehensive literature review. Preprints [Internet]. 2020 Jun [cited 2020 July 8]
3. 3. World Health Organization Coronavirus Disease (COVID-19) Dashboard. Available online:https://who. sprinklr.com/
4. 4. Garciaa P,FumeauxaT, Guercia P et al. Prognostic factors associated with mortality risk and disease progression in 639 critically ill patients with COVID-19 in Europe: Initial report of the international RISC-19-ICU prospective observational cohort. EClinicalMedicine. 2020 Aug; 25:100449. doi.: 10.1016/j.eclinm.2020.100449. Epub 2020Jul 6.
5. 5. Choudhri AF, Siddiqui A, Khan NR et al. Understanding bibliometric parameters and analysis. 2015 May-Jun;35(3):736-46. doi: 10.1148/rg.2015140036. PMID: 25969932
6. 6. Yu Y, Li Y, Zhang Y et al. A bibliometric analysis using VOSviewer of publications on COVID-19. Ann Transl Med.2020 Jul;8(13):816.doi: 10.21037/atm-20-4
7. 7.Buyukcoban S, Oner O, Hancı V. A Bibliometric Analysis of the most cited articles in geriatric anaesthesia. Turkish Journal of Geriatrics DOI: 10.31086/tjgeri.2020.177 2020; 23(3): 410-418
8. 8. Prof.Luciano Gattinoni. Critical Care Canada Forum. Accessed Nov. 21, 2020 https://criticalcarecanada.com/speaker/prof-luciano-gattinoni/

9. 9. Lou J, Tian SJ, Niu SM, et al. Coronavirus disease 2019: a bibliometric analysis and review. Eur Rev Med Pharmacol Sci. 2020 Mar;24(6):3411-3421. doi: 10.26355/eurrev_202003_20712.
10. 10. Moradian et al. The urgent need for integrated science to fight COVID-19 pandemic and beyond. J Transl Med (2020) 18:205 https://doi.org/10.1186/s12967-020-02364-2
11. 11. Tay MZ, Poh CM, Rénia et al. The trinity of COVID-19: immunity, inflammation and intervention. Nat Rev Immunol. 2020 Jun;20(6):363-374. doi: 10.1038/s41577-020-0311-8.
12. 12. Su Y, Long C, Yu Q, et al. Global scientific collaboration in COPD research. Int J Chron Obstruct Pulmon Dis. 2017 Jan 6;12:215-225. doi: 10.2147/COPD.S124051. eCollection 2017.PMID: 28123294
13. 13. Fontelo P, Liu F. A review of recent publication trends from top publishing countries. Syst Rev. 2018 Sep 27;7(1):147. doi: 10.1186/s13643-018-0819-1.PMID: 30261915
14. 14 .She J, Liu L, Liu W. Covid-19 epidemic :Disease characterics in children. J Med Virol. 2020 Jul;92(7):747-754. doi: 10.1002/jmv.25807. Epub 2020 Apr 15.PMID: 32232980
15. 15. Grein J, Ohmagari N, Shin D, et al. Compassionate Use of Remdesivir for Patients with Severe Covid-19. N Engl J Med 2020;382:2327-36.
16. 16. Vankadari NA. A potential antiviral drug for the treatment of SARS-CoV-2 by blocking trimerization of the spike glycoprotein. Int J Antimicrob Agents 2020. [Epub ahead of print].
17. 17. Cao B, Wang Y, Wen D, et al. A Trial of Lopinavir- Ritonavir in Adults Hospitalized with Severe Covid-19. N Engl J Med 2020;382:1787-99.
18. 18. Yousefi B, Valizadeh S, Ghaffari H, et al. A global treatments for coronaviruses including COVID-19. J Cell Physiol 2020.
19. 19. Yadava SM, Patrick HS, Ananth CV et al.. Top-cited articles in journal :a bibliometric analysis. Am J Obstet Gynecol. 2019 Jan;220(1):12-25. doi: 10.1016/j.ajog.2018.11.1091. Epub 2018 Nov 16
20. 20. Brown A, Horton R. A planetary health perspective on COVID-19: a call for papers. Lancet 2020;395:1099.
21. 21. Yeo-Teh NSL, Tang BL An alarming retraction rate for scientific publications on Coronavirus Disease 2019 (COVID-19). Account Res. 2020 Jun 23:1-7. doi: 10.1080/08989621.2020.1782203. PMID: 32573274